Richard R. DeLuca Jr. - 02 May 2023 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role: EVP&Pres, Merck Animal Heallth
Signature: /s/ Kelly E. W. Grez as Attorney-in-Fact for Richard R. DeLuca, Jr.
Issuer symbol: MRK
Transactions as of: 02 May 2023
Net transactions value: $0
Form type: 4
Filing time: 04 May 2023, 18:14:53 UTC
Previous filing: 02 May 2023
Next filing: 09 Nov 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MRK	Common Stock						154,493	02 May 2023	Direct
holding	MRK	Common Stock - 401(k) Plan						1,206	02 May 2023	By 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRK	Stock Option (Right to Buy)	Award	$0	+44,260		$0.000000	44,260	02 May 2023	Common Stock	44,260	$117.89	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests and becomes exercisable in equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.